Human Monoclonal Antibodies from Translocus Mice

Molecular Biology of B Cells

Volumn , Issue , 2004, Pages 547-561

  Brüggemann, Marianne ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84941629337     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012053641-2/50035-6     Document Type: Chapter

References (85)

1. Arulampalam V., Eckhardt L., Pettersson S. The enhancer shift: A model to explain the developmental control of IgH gene expression in B-lineage cells. Immunol Today 1997, 18:549-554.
2. Ball W.J., Kasturi R., Dey P., Tabet M., O'Donnell S., Hudson D., Fishwild D. Isolation and characterization of human monoclonal antibodies to digoxin. J Immunol 1999, 163:2291-2298.
3. Boder E.T., Midelfort K.S., Wittrup K.D. Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. Proc Natl Acad Sci U S A 2000, 97:10701-10705.
4. Brüggemann M., Caskey H.M., Teale C., Waldmann H., Williams G.T., Surani M.A., Neuberger M.S. A repertoire of monoclonal antibodies with human heavy-chains from transgenic mice. Proc Natl Acad Sci U S A 1989, 86:6709-6713.
5. Brüggemann M., Neuberger M.S. Generation of antibody repertoires in transgenic mice. Methods: A companion to methods in enzymology 1991, 159-165. eds. 2. R. Lerner, D. Burton (Eds.).
6. Brüggemann M., Neuberger M.S. Strategies for expressing human antibody repertoires in transgemic mice. Immunol Today 1996, 17:391-397.
7. Brüggemann M., Spicer C., Buluwela L., Rosewell I., Barton S., Surani M.A., Rabbitts T.H. Human antibody production in transgenic mice: Expression from 100kb of the human IgH locus. Eur J Immunol 1991, 21:1323-1326.
8. Brüggemann M., Taussig M.J. Production of human antibody repertoires in transgenic mice. Curr Opin Biotechnol 1997, 8:455-458.
9. Capecchi M.R. The new mouse genetics: Altering the genome by gene targeting. Trends Genet 1989, 5:70-76.
10. Choi T.K., Hollenbach P.W., Pearson B.E., Ueda R.M., Weddell G.N., Kurahara C.G., Woodhouse C.S., Kay R.M., Loring J.F. Transgenic mice containing a human heavy chain immunoglobulin gene fragment cloned in a yeast artificial chromosome. Nat Genet 1993, 4:117-123.
11. Cook G.P., Tomlinson I.M., Walter G., Riethman H., Carter N.P., Buluwela L., Winter G., Rabbitts T.H. A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q. Nat Genet 1994, 7:162-168.
12. Corbett S.J., Tomlinson I.M., Sonnhammer E.L., Buck D., Winter G. Sequence of the human immunoglobulin diversity (D) segment locus: A systematic analysis provides no evidence for the use of DIR segments, inverted D segments, "minor" D segments or D-D recombination. J Mol Biol 1997, 270:587-597.
13. Cumbers S.J., Williams G.T., Davies S.L., Grenfell R.L., Takeda S., Batista F.D., Sale J.E., Neuberger M.S. Generation and iterative affinity maturation of antibodies in vitro using hypermutating B-cell lines. Nat Biotechnol 2002, 20:1129-1134.
14. Davies N.P., Brüggemann M. Extension of yeast artificial chromosomes by cosmid multimers. Nucleic Acids Res 1993, 21:767-768.
15. Davies N.P., Rosewell I.R., Richardson J.C., Cook G.P., Neuberger M.S., Brownstein B.H., Norris M.L., Brüggemann M. Creation of mice expressing human antibody light chains by introduction of a yeast artificial chromosome containing the core region of the human immunoglobulin κ locus. Bi/technology 1993, 11:911-914.
16. Davies N.P., Popov A.V., Zou X., Brüggemann M. Human antibody repertoires in transgenic mice: Manipulation and transfer of YACs. Antibody engineering: A practical approach 1996, 59-76. IRL, Oxford. J. McCafferty, H.R. Hoogenboom, D.J. Chiswell (Eds.).
17. Davis C.G., Gallo M.L., Corvalan R.F. Transgenic mice as a source of fully human antibodies for the treatment of cancer. Cancer Metastasis Rev 1999, 18:421-425.
18. Diaz M., Flajnik M.F. Evolution of somatic hypermutation and gene conversion in adaptive immunity. Immol Rev 1998, 162:13-24.
19. Erlandsson L., Andersson K., Sigvardsson M., Lycke N., Leanderson T. Mice with an inactivated joining chain locus have perturbed IgM secretion. Eur J Immunol 1998, 28:2355-2365.
20. Fishwild D.M., O'Donnell S.L., Bengoechea T., Hudson D.V., Harding F., Bernhard' S.L., Jones D., Kay R.M., Higgins K.M., Schramm S.R., Lonberg N. High-avidity human Igκ monoclonal antibodies from a novel strain of minilocus transgenic mice. Nat Biotechnol 1996, 14:845-851.
21. Fournier R.E., Ruddle F.H. Microcell-mediated transfer of murine chromosomes into mouse, Chinese hamster, and human somatic cells. Proc Natl Acad Sci U S A 1977, 74:319-323.
22. Frazer J.K., Capra J.D. Immunoglobulins: Structure and function. Fundamental immunology 1999, 37-74. Lippincott-Raven, Philadelphia. 4th ed. W.E. Paul (Ed.).
23. Frippiat J.P., Williams S.C., Tomlinson I.M., Cook G.P., Cherif D., Le Paslier D., Collins J.E., Dunham I., Winter G., Lefranc M.-P. Organization of the human immunoglobulin lambda light-chain locus on chromosome 22q11.2. Hum Mol Genet 1995, 4:983-991.
24. Gordon J.W., Ruddle F.H. Gene transfer into mouse embryos: production of transgenic mice by pronuclear injection. Methods Enzymol 1983, 101:411-433.
25. Green L.L., Hardy M.C., Maynard-Currie C.E., Tsuda H., Louie D.M., Mendez M.J., Abderrahim H., Noguchi M., Smith D.H., Zeng Y., David N.E., Sasai H., Garza D., Brenner D.G., Hales J.F., McGuinness R.P., Capon D.J., Klapholz S., Jakobovits A. Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. Nat Genet 1994, 7:13-21.
26. Green L.L. Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies. J Immunol Methods 1999, 231:11-23.
27. Gura T. Magic bullets hit the target. Nature 2002, 417:584-586.
28. Harris R.S., Sale J.E., Petersen-Mahrt S.K., Neuberger M.S. AID is essential for immunoglobulin V gene conversion in a cultured B cell line. Curr Biol 2002, 12:435-438.
29. He M., Menges M., Groves M.A., Corps E., Liu H., Brüggemann M., Taussig M.J. Selection of a human anti-progesterone antibody fragment from a transgenic mouse library by ARM ribosome display. J Immunol Methods 1999, 231:105-117.
30. Hofker M.H., Walter M.A., Cox D.W. Complete physical map of the human immunoglobulin heavy chain constant region gene complex. Proc Natl Acad Sci U S A 1989, 86:5567-5571.
31. Hogan B., Beddington R., Costantini F., Lacy E. Manipulating the mouse embryo: A laboratory manual 1994, Cold Spring Harbour Press, Cold Spring Harbor, NY.
32. Houdebine L.M. The methods to generate transgenic animals and to control transgene expression. J Biotechnol 2002, 98:145-160.
33. Ignatovich O., Tomlinson I.M., Popov A.V., Brüggemann M., Winter G. Dominance of intrinsic genetic factors in shaping and human immunoglobulin Vλ repertoire. J Mol Biol 1999, 294:457-465.
34. Ishida I., Tomizuka K., Yoshida H., Tahara T., Takahashi N., Ohguma A., Tanaka S., Umehashi M., Maeda H., Nozaki C., Halk E., Lonberg N. Production of human monoclonal and polyclonal antibodies in transchromo animals. Cloning Stem Cells 2002, 4:91-102.
35. Jakobovits A., Green L.L., Hardy M.C., Maynard-Currie C.E., Tsuda H., Louie D.M., Mendez M.J., Abderrahim H., Noguchi M., Smith D.H., Zeng Y., David N.E., Sasai H., Garza D., Brenner D.G., Hales J.F., McGuinnes R.P., Capaon D.J., Klapholz S. Production of antigen-specific human antibodies from mice engineered with human heavy and light chain YACs. Ann N Y Acad Sci 1995, 764:525-535.
36. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
37. Kawasaki K., Minoshima S., Schooler K., Kudoh J., Asakawa S., de Jong P.J., Shimizu N. The organization of the human immunoglobulin λ gene locus. Genome Res 1995, 5:125-135.
38. King D.J. Applications and engineering of monoclonal antibodies 1998, Taylor and Francis Ltd., London, UK.
39. Kitamura D., Roes J., Kühn R., Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 1991, 350:423-426.
40. Klingbeil C., Hsu D.H. Pharmacology and safety assessment of humanized monoclonal antibodies for therapeutic use. Toxicol Pathol 1999, 27:1-3.
41. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256:495-497.
42. Koi M., Shimizu M., Morita H., Yamada H., Oshimura M. Construction of mouse A9 clones containing a single human chromosome tagged with neomycin-resistance gene via microcell fusion. Jpn J Cancer Res 1989, 80:413-418.
43. Kuroiwa Y., Shinohara T., Notsu T., Tomizuka K., Yoshida H., Takeda S., Oshimura M., Ishida I. Efficient modification of a human chromosome by telomere-directed truncation in high homologous recombination-proficient chicken DT40 cells. Nucleic Acids Res 1998, 26:3447-3448.
44. Kuroiwa Y., Tomizuka K., Shinohara T., Kazuki Y., Yoshida H., Ohguma A., Yamamoto T., Tanaka S., Oshimura M., Ishida I. Manipulation of human minichromosomes to carry greater than megabase-sized chromosome inserts. Nat Biotechnol 2000, 18:1086-1090.
45. Kuroiwa Y., Kasinathan P., Choi Y.J., Naeem R., Tomizuka K., Sullivan E.J., Knott J.G., Duteau A., Goldsby R.A., Osborne B.A., Ishida I., Robl J.M. Cloned transchromosomic calves producing human immunoglobulin. Nat Biotechnol 2002, 20:889-894.
46. Lonberg N., Huszar D. Human antibodies from transgenic mice. Int Rev Immunol 1995, 13:65-95.
47. Lonberg N., Taylor L.D., Harding F.A., Troustine M., Higgins K.M., Schramm S.R., Kuo C.-C., Mashayekh R., Wymore K., McCabe J.G., Munoz-O'Regan D., O'Donnell S.L., Lapachet E.S.G., Bengoechea T., Fishwild D.M., Carmack C.E., Kay R.M., Huszar D. Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature 1994, 368:856-859.
48. Magadán S., Valladares M., Suarez E., Sanjuán I., Molina A., Ayling C., Davies S.L., Zou X., Williams G.T., Neuberger M.S., Brüggemann M., Gambón F., Díaz-Espada F., González-Fernández A. Production of antigen-specific human monoclonal antibodies: comparison of mice carrying IgH/κ or IgH/κ/λ transloci. BioTechniques 2002, 33:680-690.
49. Magor B.G., Ross D.A., Pilstrom L., Warr G.W. Transcriptional enhancers and the evolution of the IgH locus. Immunol Today 1999, 20:13-17.
50. Markie D. YAC protocols. Methods in molecular biology 1996, 54. Humana Press, Totowa, NJ.
51. Matsuda F., Ishii K., Bourvagnet P., Kuma K., Hayashida H., Miyata T., Honjo T. The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J Exp Med 1998, 188:2151-2162.
52. Maynard J., Georgiou G. Antibody engineering. Annu Rev Biomed Eng 2000, 2:339-376.
53. Mendez M.J., Green L.L., Corvalan J.R., Jia X.-C., Maynard-Currie C.E., Yang X.-D., Gallo M.L., Louie D.M., Lee D.V., Erickson K.L., Luna J., Roy C.M., Abderrahim H., Kirschenbaum F., Noguchi M., Smith D.H., Fukushima A., Hales J.F., Klapholz S., Finer M.H., Davis C.G., Zsebo K.M., Jakobovits A. Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat Genet 1997, 15:146-156.
54. Mundt C.A., Nicholson I., Zou X., Popov A.V., Ayling C., Brüggemann M. Novel control motif cluster in the IgH δ3 interval exhibits B-cell specific enhancer function in early development. J Immunol 2001, 166:3315-3323.
55. Neuberger M., Brüggemann M. Mice perform a human repertoire. Nature 1997, 386:25-26.
56. Nicholson I.C., Zou X., Popov A.V., Cook G.P., Corps E.M., Humphries S., Ayling C., Xian J., Taussig M.J., Neuberger M.S., Brüggemann M. Antibody repertoires of four and five feature translocus mice carrying human immunoglobulin heavy chain and kappa and lambda light chain YACs. J Immunol 1999, 163:6898-6906.
57. Okada N., Okada H. Human IgM antibody therapy for HIV-1 infection. Microbiol Immunol 1999, 43:729-736.
58. Pachnis V., Pevny L., Rothstein R., Costantini F. Transfer of a yeast artificial chromosome carrying human DNA from Saccharomyces cerevisiae into mammalian cells. Proc Natl Acad Sci U S A 1990, 87:5109-5113.
59. Pavan W.J., Hieter P., Reeves R.H. Modification and transfer into an embryonal carcinoma cell line of a 360-kilobase human-derived yeast artificial chromosome. Mol Cell Biol 1990, 10:4163-4169.
60. Pluschke G., Joss A., Marfurt J., Daubenberger C., Kashala O., Zwickl M., Stief A., Sansig G., Schläpfer B., Linkert S., van der Putten H., Hardman N., Schröder M. Generation of chimeric monoclonal antibodies from mice that carry human immunoglobulin Cγ1 heavy or Cκ light chain gene segments. J Immunol Methods 1998, 215:27-37.
61. Popov A.V., Bützler C., Frippiat J.-P., Lefranc M.-P., Brüggemann M. Assembly and extension of yeast artificial chromosomes to build up a large locus. Gene 1996, 177:195-205.
62. Popov A.V., Zou X., Xian J., Nicholson I.C., Brüggemann M. A human immunoglobulin λ locus is similarly well expressed in mice and humans. J Exp Med 1999, 189:1611-1620.
63. Roschenthaler F., Hameister H., Zachau H.G. The 5' part of the mouse immunoglobulin kappa locus as a continuously cloned structure. Eur J Immunol 2000, 30:3349-3354.
64. Russell N.D., Corvalan J.R., Gallo M.L., Davis C.G., Pirofski L. Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci. Infect Immun 2000, 68:1820-1826.
65. Schedl A., Larin Z., Montoliu L., Thies E., Kelsey G., Lehrach H., Schütz G. A method for the generation of YAC transgenic mice by pronuclear microinjection. Nucleic Acids Res 1993, 21:4783-4787.
66. Shen M.H., Yang J., Loupart M.L., Smith A., Brown W. Human mini-chromosomes in mouse embryonal stem cells. Hum Mol Genet 1997, 6:1375-1382.
67. Shinohara T., Tomizuka K., Takehara S., Yamauchi K., Katoh M., Ohguma A., Ishida I., Oshimura M. Stability of transferred human chromosome fragments in cultured cells and in mice. Chromosome Res 2000, 8:713-725.
68. Taylor L.D., Carmack C.E., Huszar D., Higgins K.M., Mashayekh R., Sequar G., Schramm S.R., Kuo C.-C., O'Donnell S.L., Kay R.M., Woodhouse C.S., Lonberg N. Human immunoglobulin transgenes undergo rearrangement, somatic mutation and class switching in mice that lack endogenous IgM. Int Immunol 1994, 6:579-591.
69. Taylor L.D., Carmack C.E., Schramm S.R., Mashayekh R., Higgins K.M., Kuo C.-C., Woodhouse C., Kay R.M., Lonberg N. A transgenic mouse that expresses a diversity of human sequence heavy and light chain immunoglobulins. Nucleic Acids Res 1992, 20:6287-6295.
70. Tomizuka K., Shinohara T., Yoshida H., Uejima H., Ohguma A., Tanaka S., Sato K., Oshimura M., Ishida I. Double transchromosomic mice: Maintenance of two individual human chromosome fragments containing immunoglobulin heavy and kappa loci and expression of fully human antibodies. Proc Natl Acad Sci U S A 2000, 97:722-727.
71. Tomizuka K., Yoshida H., Uejima H., Kugoh H., Sato K., Ohguma A., Hayasaka M., Hanaoka K., Oshimura M., Ishida I. Functional expression and germline transmission of a human chromosome fragment in chimaeric mice. Nat Genet 1997, 16:133-143.
72. Wagner S.D., Popov A.V., Davies S.L., Xian J., Neuberger M.S., Brüggemann M. The diversity of antigen-specific monoclonal antibodies from transgenic mice bearing human immunoglobulin gene miniloci. Eur J Immunol 1994, 24:2672-2681.
73. Wagner S.D., Williams G.T., Larson T., Neuberger M.S., Kitamura D., Rajewsky K., Xian J., Brüggemann M. Antibodies generated from human immunoglobulin miniloci in transgenic mice. Nucleic Acids Res 1994, 22:1389-1393.
74. Wagner S.D., Gross G., Cook G.P., Davies S.L., Neuberger M.S. Antibody expression from the core region of the human IgH locus reconstructed in transgenic mice using bacteriophage P1 clones. Genomics 1996, 35:405-414.
75. Waldmann H., Cobbold S. The use of monoclonal antibodies to achieve immunological tolerance. Immunol Today 1993, 14:247-251.
76. Weichhold G.M., Klobeck H.G., Ohnheiser R., Combriato G., Zachau H.G. Megabase inversions in the human genome as physiological events. Nature 1990, 347:90-92.
77. Xian J., Zou X., Popov A.V., Mundt C.A., Miller N., Williams G.T., Davies S.L., Neuberger M.S., Brüggemann M. Comparison of the performance of a plasmid-based human Igκ minilocus and YAC-based human Igκ transloci for the production of a human antibody repertoire in transgenic mice. Transgenics 1998, 2:333-343.
78. Yang X.D., Jia X.C., Corvalan J.R., Wang P., Davis C.G. Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy. Crit Rev Oncol Hematol 2001, 38:17-23.
79. Yoshida H., Tomizuka K., Uejima H., Satoh K., Ohguma A., Oshimura M., Ishida I. Creation of hybridomas from mice expressing human antibody by introduction of a human chromosome. Animal cell technology: Basic and applied aspects, 10 1999, 69-73. Kluwer Academic Publishers, CITY. Y. Kitagawa, T. Matuda, S. Iijima, S. (Eds.).
80. Zachau H.G. The immunoglobulin kappa gene families of human and mouse: A cottage industry approach. Biol Chem 2000, 381:951-954.
81. Zou Y.R., Takeda S., Rajewsky K. Gene targeting in the Ig kappa locus: Efficient generation of lambda chain-expressing B cells, independent of gene rearrangements in Ig kappa. EMBO J 1993, 12:81-120.
82. Zou Y.R., Gu H., Rajewsky K. Generation of a mouse strain that produces immunoglobulin kappa chains with human constant region. Science 1993, 262:1271-1274.
83. Zou Y.R., Müller W., Gu H., Rajewsky K. Cre-loxP-mediated gene replacement: A mouse strain producing humanized antibodies. Curr Biol 1994, 4:1099-1103.
84. Zou X., Xian J., Davies N.P., Popov A.V., Brüggemann M. Dominant expression of a 1.3 Mb human Igκ locus replacing mouse light chain production. FASEB J 1996, 10:1227-1232.
85. Zou X., Piper T.A., Smith J.A., Allen N.D., Xian J., Brüggemann M. Block in development at the pre B-II to immature Bcell stage in mice without Igκ and Igλ light chain. J Immunol 2003, 170:1354-1361.